World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
44
Citations
13073
World Ranking
7044
National Ranking
3041

Overview

Masuo Ohno is affiliated with the Nathan Kline Institute for Psychiatric Research in the United States. Their research primarily focuses on Alzheimer's disease, encompassing disease mechanisms, early biomarkers, and potential therapeutic interventions.

Ohno's work spans several fields of study, predominantly medicine, with notable contributions to physiology, pharmacology, psychiatry and mental health, cognitive neuroscience, and computational theory and mathematics. Their research topics include:

  • Alzheimer's disease research and treatments
  • Cholinesterase and neurodegenerative diseases
  • Dementia and cognitive impairment research
  • Memory and neural mechanisms
  • Computational drug discovery methods
  • Health, environment, and cognitive aging

They have published in multiple peer-reviewed venues, including:

  • Neuropsychopharmacology Reports
  • Frontiers in Dementia
  • Psychopharmacology
  • Brain Research Bulletin
  • Journal of Alzheimer s Disease

Their recent papers reflect an ongoing focus on cognitive impairment and the therapeutic potential of BACE1 inhibitors in Alzheimer's disease models and preclinical stages. These include:

  • "Accelerated long-term forgetting is a BACE1 inhibitor-reversible incipient cognitive phenotype in Alzheimer's disease model mice" (2021, Neuropsychopharmacology Reports)
  • "Accelerated long-term forgetting: A sensitive paradigm for detecting subtle cognitive impairment and evaluating BACE1 inhibitor efficacy in preclinical Alzheimer's disease" (2023, Frontiers in Dementia)
  • "Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer's disease therapy" (2024, Psychopharmacology)
  • "BACE1 as an early biomarker and its relevance to risk factors for Alzheimer's disease" (2025, Brain Research Bulletin)
  • "A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease" (2024, Journal of Alzheimer s Disease)

Frequent collaborators include Abu Md Mamun Tarif and Hasi Huhe, with joint publications in the context of Alzheimer's disease therapeutics and biomarker research.

Best Publications

  • Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

    Holly Oakley;Sarah L. Cole;Sreemathi Logan;Erika Maus

  • BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease

    Masuo Ohno;Evgeny A Sametsky;Linda H Younkin;Holly Oakley

  • Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

    Rui M. Costa;Nikolai B. Federov;Jeff H. Kogan;Geoffrey G. Murphy

  • α-CaMKII-dependent plasticity in the cortex is required for permanent memory

    Paul W. Frankland;Cara O'Brien;Masuo Ohno;Alfredo Kirkwood

  • Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.

    Dun Sheng Yang;Dun Sheng Yang;Philip Stavrides;Panaiyur S. Mohan;Panaiyur S. Mohan;Susmita Kaushik

  • Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.

    Ryoichi Kimura;Masuo Ohno

  • BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice

    Masuo Ohno;Sarah L. Cole;Marina Yasvoina;Jie Zhao

  • Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.

    Masuo Ohno;Lei Chang;Wilbur Tseng;Holly Oakley

  • 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease

    Latha Devi;Masuo Ohno;Masuo Ohno

  • PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease

    Latha Devi;Masuo Ohno;Masuo Ohno

  • Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease.

    Latha Devi;Melissa J. Alldred;Melissa J. Alldred;Stephen D. Ginsberg;Stephen D. Ginsberg;Masuo Ohno;Masuo Ohno

  • Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.

    Ryoichi Kimura;Latha Devi;Masuo Ohno

  • Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease

    Latha Devi;Melissa J Alldred;Melissa J Alldred;Stephen D Ginsberg;Stephen D Ginsberg;Masuo Ohno;Masuo Ohno

  • Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer’s disease transgenic mice

    Latha Devi;Masuo Ohno;Masuo Ohno

  • Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice

    Latha Devi;Masuo Ohno

  • Roles of eIF2α kinases in the pathogenesis of Alzheimer's disease.

    Masuo Ohno;Masuo Ohno

  • Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis

    Dun-Sheng Yang;Dun-Sheng Yang;Philip Stavrides;Panaiyur S. Mohan;Panaiyur S. Mohan;Susmita Kaushik

  • Increased neuronal excitability, synaptic plasticity and learning in aged Kvβ1.1 knockout mice

    Geoffrey G. Murphy;Nikolai B. Fedorov;K.Peter Giese;Masuo Ohno

  • Inducible, pharmacogenetic approaches to the study of learning and memory.

    Masuo Ohno;Paul W. Frankland;Adele P. Chen;Rui M. Costa

  • TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.

    L Devi;M Ohno

  • Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats

    Masuo Ohno;Tsuneyuki Yamamoto;Shigenori Watanabe

Frequent Co-Authors

Shigenori Watanabe
Shigenori Watanabe Kyushu University
John F. Disterhoft
John F. Disterhoft Northwestern University
Alcino J. Silva
Alcino J. Silva University of California, Los Angeles
Donald A. Wilson
Donald A. Wilson Nathan Kline Institute for Psychiatric Research
Shigenobu Shibata
Shigenobu Shibata Waseda University
Stephen D. Ginsberg
Stephen D. Ginsberg Nathan Kline Institute for Psychiatric Research
Ralph A. Nixon
Ralph A. Nixon Nathan Kline Institute for Psychiatric Research
Daniel W. Wesson
Daniel W. Wesson University of Florida
Rui M. Costa
Rui M. Costa Columbia University
Peter St George-Hyslop
Peter St George-Hyslop Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Masuo Ohno

Trending Scientists